The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failure.

Date publication

mars 2021

Journal

Journal of cachexia, sarcopenia and muscle

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick

Tous les auteurs :
Pandhi P, Streng KW, Anker SD, Cleland JG, Damman K, Dickstein K, Pellicori P, Lang CC, Ng L, Samani NJ, Zannad F, Metra M, Rossignol P, Filippatos G, van Veldhuisen DJ, Voors AA, Ter Maaten JM

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/33742549

Résumé

Muscle wasting and unintentional weight loss (cachexia) have been associated with worse outcomes in heart failure (HF), but timely identification of these adverse phenomena is difficult. Spot urinary creatinine may be an easily accessible marker to assess muscle loss and cachexia. This study investigated the association of urinary creatinine with body composition changes and outcomes in patients with new-onset or worsening HF (WHF).

Mots clés

Acute heart failure, Muscle wasting, Urinary creatinine, Weight loss

Référence

J Cachexia Sarcopenia Muscle. 2021 Mar 20;: